IMMUNOPRECISE ANTIBODIES LTD. (the "Company” or "IPA”) (NASDAQ: IPA) (TSX VENTURE: ...
ImmunoPrecise Announces At-The-Market Facility of up to US$50 Million
IMMUNOPRECISE ANTIBODIES LTD. (the „Company” or „IPA”) (NASDAQ: IPA) (TSX VENTURE: …
IMMUNOPRECISE ANTIBODIES LTD. (the „Company” or „IPA”) (NASDAQ: IPA) (TSX VENTURE: …
IMMUNOPRECISE ANTIBODIES LTD. (the "Company” or "IPA”) (NASDAQ: IPA) (TSX VENTURE: ...